ES2052267T3 - Anticuerpos anti-rh(d) humanos modificados. - Google Patents

Anticuerpos anti-rh(d) humanos modificados.

Info

Publication number
ES2052267T3
ES2052267T3 ES90912594T ES90912594T ES2052267T3 ES 2052267 T3 ES2052267 T3 ES 2052267T3 ES 90912594 T ES90912594 T ES 90912594T ES 90912594 T ES90912594 T ES 90912594T ES 2052267 T3 ES2052267 T3 ES 2052267T3
Authority
ES
Spain
Prior art keywords
human antibodies
modified human
antibodies
reagent
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90912594T
Other languages
English (en)
Inventor
Marion Lesley Scott
Alan Robert Guest
David John Anstee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Blood Authority
Original Assignee
National Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Blood Authority filed Critical National Blood Authority
Application granted granted Critical
Publication of ES2052267T3 publication Critical patent/ES2052267T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTA INVENCION PROPORCIONA UNOS ANTICUERPOS HUMANOS ANTI-RH(D) REDUCIDOS Y BLOQUEADOS EN S DE LA SUBCLASE IGG3, SU USO COMO UN REACTIVO ANTI-RH(D) EN LA TIPIFICACION DE LA SANGRE, Y UN PROCESO PARA SU PREPARACION, ASI COMO UNA COMPOSICION FARMACEUTICA CONTENIENDO LOS ANTICUERPOS.
ES90912594T 1989-09-01 1990-08-31 Anticuerpos anti-rh(d) humanos modificados. Expired - Lifetime ES2052267T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919761A GB8919761D0 (en) 1989-09-01 1989-09-01 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2052267T3 true ES2052267T3 (es) 1994-07-01

Family

ID=10662373

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90912594T Expired - Lifetime ES2052267T3 (es) 1989-09-01 1990-08-31 Anticuerpos anti-rh(d) humanos modificados.

Country Status (9)

Country Link
EP (1) EP0489771B1 (es)
AT (1) ATE105570T1 (es)
AU (1) AU645263B2 (es)
CA (1) CA2065278A1 (es)
DE (1) DE69008859T2 (es)
DK (1) DK0489771T3 (es)
ES (1) ES2052267T3 (es)
GB (1) GB8919761D0 (es)
WO (1) WO1991003492A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0513706A (pt) 2004-07-20 2008-05-13 Symphogen As anticorpo policlonal recombinante anti-rhesus d e métodos de produção
RU2426795C2 (ru) 2004-07-20 2011-08-20 Симфоген А/С Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296090A (en) * 1979-07-13 1981-10-20 Ortho Diagnostics, Inc. Anti-D test and reagent
NZ194251A (en) * 1979-07-13 1983-06-17 Ortho Diagnostics Rapid determination of antigens on red blood cells and reagent therefor
NZ194363A (en) * 1979-12-26 1982-12-21 Gamma Biologicals Inc Producing anti-serum
AU622417B2 (en) * 1987-09-18 1992-04-09 National Blood Authority Human anti-rh(d) monoclonal antibodies
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
AU623345B2 (en) * 1987-09-18 1992-05-14 National Blood Authority Human anti-rh(d) monoclonal antibodies
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies

Also Published As

Publication number Publication date
ATE105570T1 (de) 1994-05-15
AU6185690A (en) 1991-04-08
WO1991003492A1 (en) 1991-03-21
DK0489771T3 (da) 1994-06-13
EP0489771B1 (en) 1994-05-11
DE69008859T2 (de) 1994-09-08
EP0489771A1 (en) 1992-06-17
CA2065278A1 (en) 1991-03-02
AU645263B2 (en) 1994-01-13
DE69008859D1 (de) 1994-06-16
GB8919761D0 (en) 1989-10-18

Similar Documents

Publication Publication Date Title
IE842979L (en) Desulfatohirudins
PT83873B (pt) Processo de preparacao de medicamentos contendo hexadecilfosfocolina
EE200000318A (et) Uudsed ühendid
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
ATE72963T1 (de) Konditionierfluessigkeiten von zahn- oder knochensubstanz.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DK157016C (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat, laegemidler indeholdende dette samt fremstilling af disse laegemidler
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
ATE67507T1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IT8721436A0 (it) "derivati di 2,3,4,5,6,7 esaidro 2,7 metano 1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
NO905496D0 (no) Biologisk forenelige, stoff-spesifikke reagenser til behandling av fysiologiske vaesker.
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
ZA885337B (en) Leukotriene antagonists,a process for the preparation thereof,and the use thereof for the treatment of diseases
AU2713288A (en) Human-type serum obtained from fractions resulting from the fractionation of human blood or serum, process for its preparation and laboratory reaction containing said serum
AU4721185A (en) Protein absorption enhancing agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 489771

Country of ref document: ES